Prosecution Insights
Last updated: May 29, 2026

Otsuka Medical Devices Co. Ltd.

9 pending office actions • 4 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days

Portfolio Summary

9
Total Pending OAs
6
Non-Final OAs
2
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
0
Due this week
3
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 30 days (3)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
8
Medium (89%)
0
Easy (0%)
1
Unknown (11%)

Rejection Statute Mix

BucketCases
§103 only8 (89%)
No statute on record1 (11%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
9
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

90 h
Manual time on pending OAs
18 h
Time saved (low, 20%)
31 h
Time saved (mid, 35%)
0.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ROY, BAISAKHI 1 77.3% +19.0%
CWERN, JONATHAN 1 50.7% +35.3%
LANCASTER, LINDSAY REGAN 1 55.1% +26.3%
HUSSAINI, ATTIYA SAYYADA 1 57.1% +14.5%
BLAISE, BRADFORD CHRISTOPHER 1 59.7% +34.1%
ZIEGLER, ABIGAIL M 1 43.6% +49.7%
RHODES, NORA W 1 51.5% +26.2%
PAPE, ALYSSA MORGAN 1 27.3% +64.8%
MCGINNITY, JAMES RYAN 1 57.3% +51.7%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17812696 TREATMENT SYSTEM HAVING GENERATOR AND FLUID TRANSFER CARTRIDGE PAPE, ALYSSA MORGAN 28d

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18182821 USING CHARACTERISTICS OF NATIVE OR EVOKED SENSED NEURAL ACTIVITY TO SELECT DENERVATION PARAMETERS ZIEGLER, ABIGAIL M 66d overdue
18937003 SYSTEMS AND METHODS FOR REAL-TIME TRACKING OF A TARGET TISSUE USING IMAGING BEFORE AND DURING THERAPY DELIVERY ROY, BAISAKHI 28d overdue
17208378 WIRE-EQUIPPED STENT, CATHETER, AND CATHETER-STENT SYSTEM MCGINNITY, JAMES RYAN 28d overdue
18327280 METHODS, DEVICES AND SYSTEMS THAT USE ONE OR MORE TRANSDUCERS TO HEAT NERVES TO EVOKE NEURAL RESPONSE WITHOUT DENERVATING NERVES, AS WELL AS TO DENERVATE NERVES BLAISE, BRADFORD CHRISTOPHER 17d overdue
18481220 DEVICES, METHODS AND SYSTEMS FOR RENAL DENERVATION LANCASTER, LINDSAY REGAN 15d
17817540 THERAPEUTIC ULTRASOUND TISSUE TREATMENT SYSTEMS, APPARATUSES, AND METHODS RHODES, NORA W 26d
17812696 TREATMENT SYSTEM HAVING GENERATOR AND FLUID TRANSFER CARTRIDGE PAPE, ALYSSA MORGAN 28d
18340241 METHODS AND SYSTEMS FOR MEASURING RENAL NEURAL ELECTRICAL ACTIVITY BY ELECTRICALLY STIMULATING IN ABDOMINAL AORTA AND SENSING EVOKED NEURAL ELECTRICAL RESPONSE IN RENAL ARTERY HUSSAINI, ATTIYA SAYYADA 42d

Top Art Units

Art UnitApps
3794 5
3797 2
3792 1
3771 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18937003 SYSTEMS AND METHODS FOR REAL-TIME TRACKING OF A TARGET TISSUE USING IMAGING BEFORE AND DURING THERAPY DELIVERY ROY, BAISAKHI 3797 §103 Non-Final OA 28d overdue Pending Nov 04, 2024
18659628 TISSUE TREATMENT CATHETER HAVING PORT BRACE CWERN, JONATHAN 3797 §103 Final Rejection 70d Pending May 09, 2024
18481220 DEVICES, METHODS AND SYSTEMS FOR RENAL DENERVATION LANCASTER, LINDSAY REGAN 3794 §103 Non-Final OA 15d Pending Oct 04, 2023
18340241 METHODS AND SYSTEMS FOR MEASURING RENAL NEURAL ELECTRICAL ACTIVITY BY ELECTRICALLY STIMULATING IN ABDOMINAL AORTA AND SENSING EVOKED NEURAL ELECTRICAL RESPONSE IN RENAL ARTERY HUSSAINI, ATTIYA SAYYADA 3792 §103 Non-Final OA 42d Pending Jun 23, 2023
18327280 METHODS, DEVICES AND SYSTEMS THAT USE ONE OR MORE TRANSDUCERS TO HEAT NERVES TO EVOKE NEURAL RESPONSE WITHOUT DENERVATING NERVES, AS WELL AS TO DENERVATE NERVES BLAISE, BRADFORD CHRISTOPHER 3794 §103 Non-Final OA 17d overdue Pending Jun 01, 2023
18182821 USING CHARACTERISTICS OF NATIVE OR EVOKED SENSED NEURAL ACTIVITY TO SELECT DENERVATION PARAMETERS ZIEGLER, ABIGAIL M 3794 §103 Non-Final OA 66d overdue Pending Mar 13, 2023
17817540 THERAPEUTIC ULTRASOUND TISSUE TREATMENT SYSTEMS, APPARATUSES, AND METHODS RHODES, NORA W 3794 §103 Non-Final OA 26d Pending Aug 04, 2022
17812696 TREATMENT SYSTEM HAVING GENERATOR AND FLUID TRANSFER CARTRIDGE PAPE, ALYSSA MORGAN 3794 Non-Final OA 28d Pending Jul 14, 2022
17208378 WIRE-EQUIPPED STENT, CATHETER, AND CATHETER-STENT SYSTEM MCGINNITY, JAMES RYAN 3771 §103 Final Rejection 28d overdue Pending Mar 22, 2021

Managing Otsuka Medical Devices Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month